全球牙菌斑修復及去除設備市場

到 2030 年，全球牙菌斑修復和去除設備市場規模將達到 30 億美元

全球牙菌斑修復和去除設備市場規模預計在2024年達到20億美元，預計在2024-2030年的分析期內將以7.3%的複合年成長率成長，到2030年將達到30億美元。動脈粥狀動脈粥狀硬化斑塊切除術設備是本報告分析的細分市場之一，預計其複合年成長率將達到8.8%，到分析期結束時將達到14億美元。血栓切除設備細分市場在分析期間的複合年成長率預計為5.0%。

美國市場規模估計為 5.329 億美元，中國市場預計複合年成長率為 11.6%

預計2024年，美國牙菌斑修復去除設備市場規模將達到5.329億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到6.364億美元，在2024-2030年的分析期間內，複合年成長率為11.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.5%和7.1%。在歐洲，預計德國市場的複合年成長率為4.8%。

全球牙菌斑修復和去除設備市場—主要趨勢和促進因素摘要

由於心血管疾病 (CVD) 盛行率的不斷上升、微創技術的進步以及導管式斑塊清除技術的偏好，牙菌斑修復和清除設備市場正在經歷顯著成長。隨著動脈粥狀硬化和周邊動脈疾病(PAD) 的日益普遍，對有效安全的斑塊清除技術的需求日益成長，尤其是在老齡化人口以及糖尿病、肥胖症和高血壓患者群體中。

影響市場發展的關鍵趨勢之一是微創斑塊清除技術的日益普及。與傳統外科手術相比，該技術能夠縮短患者恢復時間、降低手術風險並改善長期療效。動脈粥狀硬化斑塊切除術斑塊切除設備、雷射斑塊清除系統和機械血栓切除工具正變得越來越先進，能夠精準定位並更安全地清除冠狀動脈和周邊動脈中的斑塊。這些技術創新尤其有利於複雜鈣化病變、慢性完全閉塞性病變 (CTO) 和高風險心血管疾病患者。

市場成長的另一個關鍵驅動力是將先進的影像和導航技術融入斑塊修復設備。血管內超音波(IVUS)、光同調斷層掃瞄(OCT) 和即時血管造影術輔助導引系統正在增強斑塊表徵、病灶評估和手術準確性。這些影像技術使心臟科醫師和血管外科醫師能夠確定斑塊成分、最佳化器械選擇並徹底修復病變，從而降低再狹窄和併發症的血管再阻塞。

此外，生物可吸收支架和藥物塗層球囊技術的興起正在補充斑塊清除策略，從而實現持續的血管通暢和改善的術後結果。隨著監管部門的核准不斷擴大和臨床試驗證明的長期療效，全球醫院和門診手術中心 (ASC) 對下一代斑塊清除和矯正解決方案的需求預計將成長。

科技創新如何改變斑塊改造設備？

斑塊修復產業正經歷快速的技術進步，重點是儀器精度、降低手術風險和改善患者預後。新一代動脈動脈粥狀硬化斑塊切除術設備、射頻雷射系統和機械抽吸血栓切除設備正在提高複雜高風險患者斑塊清除的有效性。

該領域最顯著的創新之一是軌道式和旋轉式動脈粥狀動脈粥狀硬化斑塊切除術術設備的開發。這些以導管為基礎的系統採用差異化切割技術，選擇性地去除鈣化斑塊，同時保留健康動脈組織的完整性。鑽石塗層鑽頭和旋轉能量的使用可以精確矯正動脈斑塊，改善血流並減少重複干預的需要。

另一項突破是基於雷射的斑塊清除系統，該系統利用高能量雷射脈衝汽化動脈粥樣硬化斑塊。這些設備精度高，可減少對血管壁的損傷，並提高支架內血管再阻塞治療的效果。尤其是準分子雷射導管，已被證明在複雜的冠狀動脈和周邊血管介入治療中非常有效，斑塊施加機械力即可控制性地斑塊。

除了機械和雷射方法外，超音波增強和衝擊波碎石技術已成為治療鈣化斑塊的有前景的選擇。血管內碎石術 (IVL) 可釋放聲壓碎裂硬化斑塊，從而以最小的血管創傷將斑塊去除。該技術在複雜的介入心臟病學中正被廣泛採用，尤其是在糖尿病患者以及常規治療難以治癒的嚴重鈣化病變。

此外，針對斑塊的生物工程奈米顆粒和藥物釋放型斑塊修飾裝置正在開發中，旨在實現靶向斑塊溶解和血管穩定。這些基於奈米技術的解決方案有望降低手術風險，最大程度地減少發炎反應，並提高斑塊清除手術的持久性，是未來研究和臨床應用的重要重點。

臨床應用和最終用戶偏好如何影響市場需求？

周邊動脈疾病(PAD)、頸動脈疾病和冠狀動脈疾病 (CAD) 的盛行率不斷上升，顯著影響了牙菌斑修復和清除設備的需求。隨著越來越多的患者尋求非手術干預治療動脈阻塞，醫院、心血管診所和門診手術中心 (ASC) 正在採用先進的斑塊清除技術來滿足臨床需求。

周邊血管介入是發展最快的領域之一，其中動脈粥狀硬化斑塊動脈粥狀硬化斑塊切除術和雷射斑塊清除裝置被廣泛用於治療股動脈和膝下動脈閉塞。周邊動脈疾病 (PAD) 影響全球數百萬人，如果不及時治療，可能導致危急性肢體缺血(CLI) 和截肢。導管斑塊清除裝置的出現顯著提高了肢體存活率和長期血管通暢性，使其成為現代血管外科的重要組成部分。

冠狀動脈介入治療領域也擴大採用斑塊修復技術，尤其是在球囊血管成形術或置入術無效的鈣化冠狀動脈病變患者。旋動脈粥狀硬化斑塊切除術、血管內碎石術和雷射斑塊清除術目前是高經皮經皮冠狀動脈介入治療 (PCI) 的首選方案，可改善病灶準備和支架置入術的療效。

另一個新興應用是頸動脈疾病的治療，斑塊清除裝置有助於預防中風和腦血管事件。混合斑塊修復技術，將動脈粥狀硬化切除術術與栓塞保護過濾器和藥物塗層球囊相結合，改善了頸重組的療效，並降低了遠端栓塞和血管再阻塞的風險。

此外，門診心血管手術在心臟外科中心 (ASC) 和診室實驗室 (OBL) 的應用日益增多，也推動了對緊湊易用的斑塊清除設備的需求。一次性導管式動脈粥狀動脈粥狀硬化斑塊切除術系統和經濟高效的雷射平台可實現當天出院並減少住院時間，使斑塊修復治療對更廣泛的患者群體更易於獲得且更經濟實惠。

哪些因素推動了牙菌斑改造和去除設備市場的成長？

牙菌斑修復和去除設備市場的成長受到多種因素的推動，包括微創心血管手術的進步、周邊和冠狀動脈疾病的盛行率增加、即時成像和人工智慧主導的分析的整合以及門診心血管護理環境的擴展。

全球動脈粥狀硬化和心血管疾病 (CVD) 負擔日益加重，是市場的主要驅動力。人口老化、久坐不動的生活方式以及代謝紊亂（例如糖尿病和肥胖症）的持續上升，推動了對有效的導管斑塊清除解決方案的需求。醫生們正在尋求更安全、更快速、更持久的干涉措施，精準動脈粥狀動脈粥狀硬化斑塊切除術、雷射消熔和震波碎石術已成為現代心血管醫學的重要工具。

另一個關鍵促進因素是人工智慧輔助影像處理和手術導航系統的快速發展。人工智慧平台增強了術前規劃、術中指導和術後監測，使介入醫生能夠檢測複雜斑塊、最佳化設備選擇並提高手術安全性。人工智慧與血管內超音波 (IVUS)、光學相干斷層掃描 (OCT) 和血管造影術的結合顯著降低了併發症發生率、再血管再阻塞風險和手術失敗率，進一步促進了市場應用。

門診循環系統護理的擴展和門診手術中心 (ASC) 的興起也推動了市場的成長。隨著醫療保健系統轉向經濟高效的當日手術，對攜帶式、易於使用的斑塊清除技術的需求日益成長。各公司正在推出一次性斑塊動脈粥狀硬化斑塊切除術設備、微型雷射系統和一次性碎石導管，以促進從醫院到門診的醫療服務轉型。

此外，下一代斑塊修復設備的監管核准和臨床試驗的成功正在加速其商業化進程。主要企業正在投資生物可吸收支架、基於奈米技術的斑塊標靶治療以及混合動脈粥狀硬化斑塊切除術切除術-支架系統的研發，以確保長期血管通暢性並改善心血管健康狀況。

隨著精準心血管介入的需求不斷成長，隨著技術進步、人工智慧主導的診斷和微創治療的創新塑造動脈粥狀硬化管理和血管醫學的未來，牙菌斑修改和去除設備市場預計將大幅擴張。

部分

產品（動脈粥狀硬化斑塊切除術裝置、血栓除去裝置、慢性阻塞裝置、栓塞保護裝置）；應用（冠狀動脈疾病、周邊動脈疾病）；最終用途（醫院、門診手術中心、其他）

受訪公司範例

• Abbott Laboratories
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Avinger, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company（BD）
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cardiovascular Systems, Inc.
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic plc
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Philips Healthcare
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Plaque Modification and Removal Devices Market to Reach US$3.0 Billion by 2030

The global market for Plaque Modification and Removal Devices estimated at US$2.0 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Atherectomy Devices, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Thrombectomy Devices segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$532.9 Million While China is Forecast to Grow at 11.6% CAGR

The Plaque Modification and Removal Devices market in the U.S. is estimated at US$532.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$636.4 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Plaque Modification and Removal Devices Market - Key Trends & Drivers Summarized

The plaque modification and removal devices market is witnessing significant growth, driven by rising cases of cardiovascular diseases (CVDs), advancements in minimally invasive procedures, and increasing preference for catheter-based plaque removal techniques. As atherosclerosis and peripheral artery disease (PAD) become more prevalent, the need for effective and safe plaque removal technologies is growing, particularly among aging populations and individuals with diabetes, obesity, and hypertension.

One of the major trends shaping the market is the increasing adoption of minimally invasive plaque removal techniques, which offer faster recovery times, reduced procedural risks, and improved long-term outcomes compared to traditional surgical methods. Atherectomy devices, laser-based plaque removal systems, and mechanical thrombectomy tools are becoming more sophisticated, enabling precise targeting and safer plaque removal in coronary and peripheral arteries. These innovations are particularly beneficial for patients with complex calcified lesions, chronic total occlusions (CTOs), and high-risk cardiovascular conditions.

Another key driver of market growth is the integration of advanced imaging and navigation technologies in plaque modification devices. Intravascular ultrasound (IVUS), optical coherence tomography (OCT), and real-time angiography-assisted guidance systems are enhancing plaque characterization, lesion assessment, and procedural accuracy. These imaging techniques allow cardiologists and vascular surgeons to determine plaque composition, optimize device selection, and ensure complete lesion modification, reducing the risk of restenosis and complications.

Additionally, the rise of bioresorbable stents and drug-coated balloon technologies is complementing plaque removal strategies, providing sustained vessel patency and improved post-procedural outcomes. With regulatory approvals expanding and clinical trials demonstrating positive long-term efficacy, the demand for next-generation plaque removal and modification solutions is expected to rise in both hospital settings and ambulatory surgical centers (ASCs) worldwide.

How Are Technological Innovations Transforming Plaque Modification Devices?

The plaque modification industry is undergoing rapid technological advancements, with a strong focus on device precision, reduced procedural risks, and improved patient outcomes. Next-generation atherectomy devices, high-frequency laser systems, and mechanical aspiration thrombectomy tools are enhancing the effectiveness of plaque removal in complex and high-risk patients.

One of the most notable innovations in the field is the development of orbital and rotational atherectomy devices. These catheter-based systems use differential cutting technology to selectively remove calcified plaque while preserving the integrity of healthy arterial tissue. The use of diamond-coated burrs and rotational energy allows for precise modification of arterial plaques, improving blood flow and reducing the need for repeat interventions.

Another groundbreaking advancement is laser-based plaque removal systems, which utilize high-energy laser pulses to vaporize atherosclerotic plaques. These devices offer exceptional precision, reduced trauma to vessel walls, and enhanced efficacy in treating in-stent restenosis. Excimer laser catheters, in particular, are proving to be highly effective in complex coronary and peripheral interventions, allowing controlled ablation of calcified and fibrotic plaques without mechanical force.

In addition to mechanical and laser-based approaches, ultrasound-enhanced and shockwave lithotripsy technologies are emerging as promising alternatives for calcified plaque modification. Intravascular lithotripsy (IVL) delivers acoustic pressure waves to fracture hardened plaques, facilitating their removal with minimal vessel trauma. This technique is gaining widespread adoption in complex cardiovascular interventions, particularly in patients with diabetes and heavily calcified lesions that are resistant to traditional treatments.

Moreover, bioengineered plaque-targeting nanoparticles and drug-eluting plaque modification devices are in development to provide targeted plaque dissolution and vessel stabilization. These nanotechnology-based solutions are expected to reduce procedural risks, minimize inflammatory responses, and enhance the durability of plaque removal procedures, making them a key focus for future research and clinical applications.

How Are Clinical Applications and End-User Preferences Shaping Market Demand?

The demand for plaque modification and removal devices is heavily influenced by the increasing prevalence of peripheral artery disease (PAD), carotid artery disease, and coronary artery disease (CAD). As more patients seek non-surgical interventions for arterial blockages, hospitals, specialty cardiovascular clinics, and ambulatory surgical centers (ASCs) are adopting advanced plaque removal technologies to meet clinical demands.

One of the fastest-growing segments is peripheral vascular interventions, where atherectomy and laser plaque removal devices are widely used to treat femoropopliteal and infrapopliteal arterial blockages. PAD affects millions of people worldwide, leading to critical limb ischemia (CLI) and potential limb amputation if left untreated. The availability of catheter-based plaque removal tools has significantly improved limb salvage rates and long-term vessel patency, making these devices essential in modern vascular surgery.

The coronary intervention sector is also seeing increased adoption of plaque modification technologies, particularly in patients with calcified coronary lesions that are resistant to balloon angioplasty and stenting. Rotational atherectomy, intravascular lithotripsy, and laser-assisted plaque removal are now preferred options for high-risk percutaneous coronary interventions (PCIs), offering better lesion preparation and stent expansion outcomes.

Another emerging application is in the treatment of carotid artery disease, where plaque removal devices are helping to prevent stroke and cerebrovascular events. Hybrid plaque modification techniques, combining atherectomy with embolic protection filters and drug-coated balloons, are enhancing carotid revascularization outcomes, reducing the risk of distal embolization and restenosis.

Moreover, the rising adoption of outpatient cardiovascular procedures in ASCs and office-based labs (OBLs) is driving demand for compact, user-friendly plaque removal devices. Single-use, disposable catheter-based atherectomy systems and cost-effective laser platforms are enabling same-day discharge and reduced hospital stays, making plaque modification treatments more accessible and affordable for a broader patient population.

What Factors Are Driving the Growth of the Plaque Modification and Removal Devices Market?

The growth in the plaque modification and removal devices market is driven by several factors, including advancements in minimally invasive cardiovascular procedures, increasing prevalence of peripheral and coronary artery diseases, the integration of real-time imaging and AI-driven analytics, and the expansion of outpatient cardiovascular care settings.

The rising global burden of atherosclerosis and cardiovascular disease (CVD) is a primary market driver. As aging populations, sedentary lifestyles, and metabolic disorders (such as diabetes and obesity) continue to rise, the demand for effective, catheter-based plaque removal solutions is increasing. Physicians are seeking safer, faster, and more durable interventions, making high-precision atherectomy, laser ablation, and shockwave lithotripsy devices critical tools in modern cardiovascular medicine.

Another key factor is the rapid development of AI-assisted imaging and procedural navigation systems. AI-powered platforms are enhancing pre-procedural planning, intraoperative guidance, and post-procedural monitoring, allowing interventionalists to detect complex plaques, optimize device selection, and improve procedural safety. The integration of AI with IVUS, OCT, and angiography is significantly reducing complication rates, restenosis risks, and procedural failures, further driving market adoption.

The expansion of outpatient cardiovascular care and the rise of ambulatory surgical centers (ASCs) are also fueling market growth. With healthcare systems shifting toward cost-effective, same-day procedures, the demand for portable, easy-to-use plaque removal technologies is increasing. Companies are introducing disposable atherectomy devices, compact laser systems, and single-use lithotripsy catheters to support the transition from hospital-based interventions to office-based treatments.

Moreover, regulatory approvals and clinical trial success in next-generation plaque modification devices are accelerating commercialization. Leading companies are investing in research and development (R&D) for bioresorbable scaffolds, nanotechnology-based plaque-targeting therapies, and hybrid atherectomy-stent systems, ensuring long-term vessel patency and improved cardiovascular health outcomes.

As the demand for precision-based cardiovascular interventions continues to grow, the plaque modification and removal devices market is expected to expand significantly, with technological advancements, AI-driven diagnostics, and minimally invasive treatment innovations shaping the future of atherosclerosis management and vascular health care.

SCOPE OF STUDY:

The report analyzes the Plaque Modification and Removal Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices, Embolic Protection Devices); Application (Coronary Artery Disease, Peripheral Artery Disease); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Avinger, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cardiovascular Systems, Inc.
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic plc
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Philips Healthcare
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Plaque Modification and Removal Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Peripheral and Coronary Artery Disease Drives Demand for Plaque Modification Devices
  • Increased Use of Endovascular Procedures Spurs Adoption of Atherectomy and Thrombectomy Technologies
  • Technological Innovations in Rotational, Orbital, and Laser-Based Atherectomy Enhance Precision and Efficacy
  • Shift Toward Minimally Invasive Cardiovascular Interventions Strengthens Demand for Plaque Removal Systems
  • Aging Population and Rising Diabetic Patient Base Expand the Target Pool for PAD and CAD Therapies
  • Surge in Complex Lesions and Calcified Arteries Spurs Development of Specialty Modification Devices
  • Regulatory Approvals and Favorable Reimbursement in Developed Markets Accelerate Procedure Volumes
  • Integration of Imaging-Guided and AI-Driven Device Navigation Improves Safety and Clinical Outcomes
  • Hospital Infrastructure Modernization and Hybrid Cath Lab Expansion Support Device Adoption
  • Increasing Adoption of Drug-Coated Balloons and Stents Encourages Pre-Treatment with Debulking Devices
  • Strategic Collaborations Between Medtech Firms and Cardiovascular Specialists Accelerate Innovation
  • Growth of Ambulatory Surgery Centers (ASCs) Enhances Use of Portable and Cost-Efficient Devices
  • Surge in Clinical Trials and Real-World Evidence Supporting Efficacy of Plaque Removal Boosts Physician Confidence
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Plaque Modification and Removal Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Plaque Modification and Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Atherectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Atherectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Atherectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Thrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Chronic Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Chronic Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Chronic Occlusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Coronary Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• JAPAN
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• CHINA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• EUROPE
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Plaque Modification and Removal Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• FRANCE
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• GERMANY
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• INDIA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Plaque Modification and Removal Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Plaque Modification and Removal Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• AFRICA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION